Exclusive Collaboration to Apply Breakthrough Extraction Technologies to Cannabis

Vancouver, BC – December 14, 2016 – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB)(OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Radient Technologies Inc. (“Radient”) (TSXV:RTI) are pleased to announce that they have signed a memorandum of understanding (“MOU”) to evaluate an exclusive partnership for the Canadian market with regard to the joint development and commercialization of superior and standardized cannabinoid extracts. As part of the MOU, Aurora will, subject to certain conditions precedent being satisfied, invest up to $2 million into Radient by means of a convertible debenture (the “Debenture”).

The full article can be accessed here.